HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yun-Cheol Na Selected Research

timosaponin AIII

4/2022Timosaponin A3 Inhibits Palmitate and Stearate through Suppression of SREBP-1 in Pancreatic Cancer.
3/2019Apoptosis and G2/M cell cycle arrest induced by a timosaponin A3 from Anemarrhena asphodeloides Bunge on AsPC-1 pancreatic cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yun-Cheol Na Research Topics

Disease

3Neoplasms (Cancer)
04/2022 - 06/2007
3Type 2 Diabetes Mellitus (MODY)
10/2016 - 08/2015
2Pancreatic Neoplasms (Pancreatic Cancer)
04/2022 - 03/2019
2Fibrosis (Cirrhosis)
10/2017 - 09/2014
2Inflammation (Inflammations)
07/2016 - 03/2016
2Fatty Liver
07/2016 - 01/2016
1Autoimmune Hepatitis
10/2017
1Metabolic Syndrome (Dysmetabolic Syndrome X)
10/2016
1Non-alcoholic Fatty Liver Disease
07/2016
1B-Cell Lymphoma (Lymphoma, B Cell)
07/2016
1Dysbiosis
03/2016
1Crohn Disease (Crohn's Disease)
03/2016
1Liver Diseases (Liver Disease)
01/2016
1Hyperglycemia
12/2015
1Hepatocellular Carcinoma (Hepatoma)
12/2015
1Wounds and Injuries (Trauma)
08/2015
1Hypersensitivity (Allergy)
01/2015
1Respiratory Hypersensitivity
01/2015
1Asthma (Bronchial Asthma)
01/2015
1Airway Obstruction (Choking)
01/2015
1Liver Cirrhosis (Hepatic Cirrhosis)
09/2014
1Alcoholic Fatty Liver
07/2014
1Carcinoma (Carcinomatosis)
02/2012
1Obesity
11/2006

Drug/Important Bio-Agent (IBA)

3Biological ProductsIBA
01/2016 - 11/2006
2timosaponin AIIIIBA
04/2022 - 03/2019
2LipidsIBA
10/2017 - 07/2016
2Hypoglycemic Agents (Hypoglycemics)IBA
01/2016 - 08/2015
2Glucagon-Like Peptide 1 (GLP 1)IBA
01/2016 - 12/2015
1Transcription Factors (Transcription Factor)IBA
04/2022
1GemcitabineFDA Link
04/2022
1PalmitatesIBA
04/2022
1Fatty Acids (Saturated Fatty Acids)IBA
04/2022
1StearatesIBA
04/2022
1PhytochemicalsIBA
03/2019
1Antineoplastic Agents (Antineoplastics)IBA
03/2019
1Transforming Growth Factors (Transforming Growth Factor)IBA
10/2017
1Concanavalin AIBA
10/2017
1SolventsIBA
10/2017
1AntibodiesIBA
10/2017
1Collagen Type I (Type I Collagen)IBA
10/2017
1Interleukin-6 (Interleukin 6)IBA
10/2017
1Therapeutic UsesIBA
10/2017
1CytokinesIBA
10/2017
1Interleukin-17 (Interleukin 17)IBA
10/2017
1Insulin (Novolin)FDA Link
10/2016
1Proteins (Proteins, Gene)FDA Link
07/2016
1Nonesterified Fatty Acids (NEFA)IBA
07/2016
1PropionatesIBA
03/2016
1Butyrates (Butyrate)IBA
03/2016
1AllergensIBA
03/2016
1Glucose (Dextrose)FDA LinkGeneric
01/2016
1Biomarkers (Surrogate Marker)IBA
01/2016
1ginsenoside Rg3IBA
12/2015
12- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
12/2015
1Galactose (Galactopyranose)FDA LinkGeneric
12/2015
1Pharmaceutical PreparationsIBA
12/2015
1Keratins (Keratin)IBA
08/2015
1OvalbuminIBA
01/2015
1Bronchodilator Agents (Bronchodilators)IBA
01/2015
1gamma-sitosterol (beta-sitosterol)IBA
09/2014
1Dimethylnitrosamine (Nitrosodimethylamine)IBA
09/2014
1JNK Mitogen-Activated Protein KinasesIBA
07/2014
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
02/2012
1SteamIBA
06/2007
1GinsenosidesIBA
06/2007
1SaponinsIBA
11/2006